—
However, in terms of volume, the global inhalers market is expected to reach 780.81 million units by 2025 with a CAGR of 13.2% during the forecast period.Buy One-Get One @ https://www.orianresearch.com/checkout/1040639
[Buy this report and get another report of the same price for free.]
OR
GET Flat 40% Discount: https://www.orianresearch.com/discount/1040639
[Avail flat 40% discount on this report.]
No of Pages: 121
The global market is primarily driven by the increase in the incidences of chronic diseases coupled with the increase in air pollution globally. In addition, rising trend of increased consumption of tobacco usage and patent expiry of inhalers as well as medications will also aid in supplementing the market growth. However, lack of awareness regarding the potential benefits of inhalers especially in developing countries might impede the market growth. The innovation in technologies of inhalers such as smart inhalers might create lucrative opportunities in the market.
The global Inhalers market is primarily segmented based on indication, product, end user and region. Based on indication the market is segmented into Chronic Obstructive Pulmonary Disease (COPD), asthma and others (pneumonia, lung fibrosis, obesity and diabetes). Based on product the market is segmented into dry powder inhalers, metered dose inhalers and nebulizers. Based on end user the market is segmented into homecare use, hospital use, and others. Further, based on region the global market is segmented into North America, Europe, Asia Pacific, South America and Middle East & Africa.
Major Players in Inhalers market are:
* Teva Pharmaceutical Industries Ltd
* Merck & Co., Inc.
* Boehringer Ingelheim
* AstraZeneca
* MannKind Corporation
* Aristopharma Ltd.
* Vectura Group Plc.
* Novartis AG
* GlaxoSmithKline Plc.
* 3M
* Orion Corporation
* Hovione
Major Regions that plays a vital role in Inhalers market are:
North America
Europe
China
Japan
Middle East & Africa
India
South America
Others
On the basis of indication, the market is split into:
* Asthma
*Chronic Obstructive Pulmonary Disease (COPD)
* Others
On the basis of product, the market is split into:
* Dry Powder Inhalers (DPIs)
* Metered Dose Inhalers (MDIs)
* Nebulizers
On the basis of End User, the market is split into:
* Homecare Use
* Hospital Use
* Others
On the basis of indication, COPD dominated the global market in 2017 owing to the increase in prevalence of COPD globally. For instance, according to the WHO in 2016, the global number of COPD patients was about 251 million.
Further, based on product, dry powder inhalers held maximum share in the global market. This is due to the advantages offered by traditional inhalers such as utilization of the inhaler in conjunction with various medications including polymeric nanoparticles, solid lipid nanoparticles, nanoaggregates and nanocomposites among others. However, metered dose inhalers are gaining traction in the recent years owing to the launch of smart inhalers. For instance, in 2018, Teva Pharmaceutical Industries Ltd launched ProAir Digihaler, which is first of its kind inhaler. This device has built in sensors that connects to a companion mobile application and provides inhaler use information to people with asthma and COPD.
Based on end user, homecare use dominated the market in 2017 owing to the self-medication trend among the global population.
Furthermore, based on region North America dominated the global market owing to the increase in launch of novel products and expiring patents. For instance, in January 2019, Mylan launched Wixela Inhub (fluticasone propionate and salmeterol inhalation powder), the first generic version of GlaxoSmithKline’s ADVAIR DISKUS for COPD and asthma. The patent on the Diskus inhaler also expired in 2016. In addition, Sandoz have tried to get the drug approval for the generic of Advair but has not succeeded yet. However, Asia Pacific is expected to be the fastest growing regional market in the forecast period owing to the rise in respiratory diseases and the increasing awareness regarding the use of inhalers.
About Us:
Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.
Contact Info:
Name: Ruwin Mendez
Email: Send Email
Organization: Orian Research
Website: https://www.orianresearch.com/report/inhalers/1040639
Release ID: 88929812
Google
RSS